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Limitations of eGFR = creatinine
If creatinine is especially « bad » for reflecting GFR (most of 
time because abnormal muscular mass), your eGFR result 
won’t be accurate
Specific population: eGFR is not 
magic!!
Keep our clinical feeling!!
Anorexia Nervosa (Delanaye P, Clin Nephrol, 2009, 71, 482)
Cirrhotic (Skluzacek PA, Am J Kidney Dis, 2003, 42, 1169)
Intensive Care (Delanaye P, BMC Nephrology, 2014, 15, 9)
Severely ill (Poggio ED, Am J Kidney Dis, 2005, 46, 242)
Heart transplanted (Delanaye P, ClinTransplant, 2006, 20, 596)
Kidney transplantation (Masson I, Transplantation, 2013, 95, 1211)
Obese (Bouquegneau A, NDT, 2013, 28, iv122)
Elderly (Schaeffner E, Ann Intern Med, 2012, 157, 471)
Hyperfiltration (Gaspari F, Kidney Int, 2013, 84, 164)
Today the true question is maybe not about which equation is the best but 
when measured GFR is required
Delanaye P, Nature Rev Nephrol, 2013, 9, 513 

Measuring GFR: Why?
A question of precision!
 Starting dialysis
 Sarcopenia 
 Extreme body size
 Cirrhosis, USI
 Fibrates, cimetidine, trimethoprim (and other therapies)
 Young women
 Hyperfiltration
 Living Kidney Donor selection
 Dosing potential nephrotoxic drug 
 EMA
Agarwal R, Nephrol Dial Transplant, 2019, in press 

Measuring GFR: Why?
A question of precision!
 Starting dialysis
 Sarcopenia 
 Extreme body size
 Cirrhosis, USI
 Fibrates, cimetidine, trimethoprim (and other therapies)
 Young women
 Hyperfiltration
 Living Kidney Donor selection
 Dosing potential nephrotoxic drug 
 EMA
 GFR follow-up
Agarwal R, Nephrol Dial Transplant, 2019, in press 
 Nephrotest Cohort
 51Cr-EDTA
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mGFR by iohexol plasma clearance
Measuring GFR: Why?
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 NO DEFINITIVE PROOF
Agarwal R, Nephrol Dial Transplant, 2019, in press 
 Why?
 How?HOW ?
Renal function: concept of clearance
 Clearance of a solute (ml/min): 
volume of plasma cleared (« purified ») of this substance per time
Cl = [U] x [V]/ [P]
 Ideal marker for GFR:
 No effect on GFR, non toxic
 Not bound to protein, freely filtrated through glomerulus
 No secretion, no absorption in the tubules
 No extra renal clearance
 Easy to measure
Available on the market…
Markers Strenghts Limitations
Inulin
Gold standard (or historic)
Safe
Costly
Dosage neither easy  nor standardized
Doubt with plasma clearance
Iothalamate
The most popular in USA
Isotopic or “cold” method
Tubular secretion
Cannot be used if allergy to iodine
Iohexol
Cannot be used if allergy to iodine
EDTA Easy to measure
Only isotopic
Not available in USA




Stevens LA, J Am Soc Nephrol, 2009, 20, 2305
Cavalier E, Clin Chim Acta, 2008, 396, 80 
Delanaye P, Clin Kidney J, 2016, 9, 700
Different markers




 Constant infusion until equilibrium
 Measurement of plasma and urinary concentrations
 Urine collection (every 30 or 60 minutes) and measuring urinary flow
To be repeated 3 or 4 times 
 Cl = [U] x [V]/ [P] (mean of 3 or 4 collections)
Plasmatic Clearance =  Dose / AUC
Not easy in practice (many samples)
Only slope ß after equilibrium is
calculated
Theoritically,  and  must be calculated
M
Brochner-Mortensen 
mathematical correction for 
estimation of distribution phase















Stolz A, Transplantation, 2010, 89, 440





Less precision, less repeatability (urine recolt!)
Differences are systematic (bias)


Delanaye P, Clin Kidney J, 2016, 9, 700
Available on the market…
Markers Strength Limitations
Inulin
“Gold standard” (or historical)
Costly
No standardized dosage,  not available in US
Impossible for plasma clearance
Anaphylactic shock
Iothalamate








EDTA Facile à mesurer
Seulement isotopique
Pas disponible aux USA…et plus en Europe!!
DTPA Facile à mesurer
Seulement isotopique
Liaison aux protéines
Stevens LA, J Am Soc Nephrol, 2009, 20, 2305
Cavalier E, Clin Chim Acta, 2008, 396, 80 
Delanaye P, Clin Kidney J, 2016, 9, 700
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The most used in Europe
Cold
Allergy Iode
EDTA Easy to measure
Only isotopic
Unavailable in US…and in Europe!!
DTPA Easy to measure
Only isotopic
Binding protein
Stevens LA, J Am Soc Nephrol, 2009, 20, 2305
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The most used in Europe
Cold
Allergy Iodine
EDTA Easy to measure
Only isotopic, costly
not available in US…and in Europe!!




Stevens LA, J Am Soc Nephrol, 2009, 20, 2305
Cavalier E, Clin Chim Acta, 2008, 396, 80 
Delanaye P, Clin Kidney J, 2016, 9, 700

Are these markers equivalent?
EDTA versus iohexolN=49
Brandstrom E, NDT, 1998, 13, 1176
Iothalamate versus iohexol





Soveri I, Am J Kidney Dis, 2014, 64, 411
 Only « cold » methods are easy to implement worldwide
 Iohexol is available worldwide
 Perfect stability (central laboratory)
 EQUAS (Equalis, Sweden) is available
Choice of the marker (personal opinion)
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 Only « cold » methods are easy to implement worldwide
 Iohexol is available worldwide
 Perfect stability (central laboratory)
 EQUAS (Equalis, Sweden) is available
 Cr-EDTA, inulin, iothalamate not (or not easily) available in Europe…
Iohexol, example of protocol
 Iohexol (plasma clearance), 5 mL bolus (Omnipaque, 240 mg I/mL)
 5 hours 
 Samples at 2, 3, 4 and 5 hours (+later if very low GFR)
 Bröchner-Mortensen correction
 ± 100 euros




 Measuring GFR is not so cumbersome (for a reference method)
 Measuring GFR is not so costly (for a reference method)
 Standardization (marker, procedure and measurement) can still be improved
 Iohexol plasma clearance is the best balance between 
physiology and feasibility
 Iohexol is safe
 Iohexol is the only chance to have a standardized GFR 
measurement worldwide
European Kidney Function Consortium (EKFC)
Thank you!
